KANGHONG Trademark

Trademark Overview


On Tuesday, May 22, 2018, a trademark application was filed for KANGHONG with the United States Patent and Trademark Office. The USPTO has given the KANGHONG trademark a serial number of 79245594. The federal status of this trademark filing is REGISTERED as of Tuesday, October 8, 2019. This trademark is owned by Chengdu Kanghong Pharmaceuticals Group Co., Ltd.. The KANGHONG trademark is filed in the Pharmaceutical Products category with the following description:

Mothproofing preparations; Radioactive substances in the nature of drugs for medical purposes; Chemico-pharmaceutical preparations for reducing blood fat; Chemico-pharmaceutical preparations for promoting sleep; Chemico-pharmaceutical preparations for sedation, anti-depression, tumor suppression; Chemico-pharmaceutical preparations for the treatment of diabetes, diseases of the central nervous system, diseases of the respiratory system, cardiovascular diseases and cancer; Chemico-pharmaceutical preparations used in eye surgery and intraocular surgery; Pharmaceutical preparations in the nature of tissues impregnated with pharmaceutical skin lotions; Depuratives for the body; Media for bacteriological cultures; Medicinal preparations for the mouth to be applied in the form of tablets; Semen for artificial insemination; Medicines for human purposes, namely, medicines for humans for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central ner...
kanghong

General Information


Serial Number79245594
Word MarkKANGHONG
Filing DateTuesday, May 22, 2018
Status700 - REGISTERED
Status DateTuesday, October 8, 2019
Registration Number5876519
Registration DateTuesday, October 8, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 23, 2019

Trademark Statements


Description of MarkThe mark consists of of a rounded chevron inside of a rectangle with rounded corners. To the right are two Chinese characters with a line underneath and the wording "KANGHONG" underneath the line.
NOT AVAILABLEThe non-Latin characters in the mark transliterate to "KANG HONG" and this has no meaning in a foreign language.
Goods and ServicesMothproofing preparations; Radioactive substances in the nature of drugs for medical purposes; Chemico-pharmaceutical preparations for reducing blood fat; Chemico-pharmaceutical preparations for promoting sleep; Chemico-pharmaceutical preparations for sedation, anti-depression, tumor suppression; Chemico-pharmaceutical preparations for the treatment of diabetes, diseases of the central nervous system, diseases of the respiratory system, cardiovascular diseases and cancer; Chemico-pharmaceutical preparations used in eye surgery and intraocular surgery; Pharmaceutical preparations in the nature of tissues impregnated with pharmaceutical skin lotions; Depuratives for the body; Media for bacteriological cultures; Medicinal preparations for the mouth to be applied in the form of tablets; Semen for artificial insemination; Medicines for human purposes, namely, medicines for humans for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; Medicines for humans to treat or prevent diabetes, coughs, colds, influenza, headaches and allergic reactions; Vermin destroying preparations; Biochemical drug for medical purposes for the treatment of cancer and ophthalmic diseases; Suppositories; Pharmaceutical preparations in the form of liquids for the treatment of central nervous system diseases, tumors, diabetes, ophthalmic diseases; Pharmaceutical preparations in the form of liquids for the treatment of cancer; Disinfectants for hygiene purposes; Mosquito-repellent incense; Sanitary sterilizing preparations in the nature of tissues impregnated with sterilization preparations; Chemical conductors for electrocardiograph electrodes; Dental lacquer; Medicinal drinks in the nature of herb liqueurs; Pharmaceutical preparations used for the relief of pain and to reduce fever; Pharmaceutical preparations for the prevention and/or treatment of cardiovascular diseases, hemophilia, metabolic diseases, cancer, multiple sclerosis, urologic diseases, sexual dysfunction, osteoporosis, and climacteric diseases; Pharmaceutical preparations, namely, anticoagulants and platelet aggregation inhibitors; anti-infective pharmaceutical preparations; Pharmaceutical preparations, namely, ophthalmics; Pharmaceutical preparations for the treatment of ophthalmic diseases and conditions; Infusions for medical purposes for treating dermatological diseases; Gases for medical purposes; Wadding for medical purposes; Drugs for medical purposes, namely, pharmaceutical preparations for anti-depression, tumor suppression, relieving cough, reducing blood pressure; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment central nervous system diseases, asthma, diabetes, respiratory system diseases, cancer, cardiovascular diseases, gastrointestinal diseases, hyperlipidaemia and hypercholesteremia; Drugs for medical purposes, namely, pharmaceutical preparations used in eye surgery and intraocular surgery; Bath preparations for medical purposes; Diagnostic agents for medical purposes; Solutions for contact lenses; Crude drugs, namely pharmaceutical preparations for the treatment of central nervous system diseases, namely hypertension, hyperlipidemia, schizophrenia and melancholia, digestive system diseases, namely dyspepsia, chronic gastritis, chronic lithogenous cholecystitis, chronic cholecystitis and gall-stone, ophthalmology system diseases, namely wet Age-related Macular Degeneration (AMD), and other diseases, namely fever, irritability, red eyes, mouth sores, sore throat, swollen gums, constipation, pharyngitis, tonsillitis, gingivitis, upper respiratory infection (URI), acute bronchitis, diabetes and nephropathy; Pharmaceutical preparations in the form of injections for the treatment of central nervous system diseases, diabetes, fundus oculi disease and cancer; Pharmaceutical preparations in the form of injections for tumor suppression; Pharmaceutical preparations in the form of injections used in eye surgery and intraocular surgery; Traditional Chinese medicines for Chinese medicinal use, namely, dried Chinese boxthorn fruits, Chinese-date, pseudo-ginseng, Chinese angelica and ginseng; Traditional Chinese medicines for Chinese medicinal use, namely, dried Chinese boxthorn fruits, Chinese-date, pseudo-ginseng, Chinese angelica and ginseng sold as a kit in a Chinese medicine bag
Pseudo MarkKANG HONG
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLETHE CHINESE CHARACTER THAT TRANSLITERATES TO "KANG"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 23, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameChengdu Kanghong Pharmaceuticals Group Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSichuan
CN

Party NameChengdu Kanghong Pharmaceuticals Group Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSichuan
CN

Party NameChengdu Kanghong Pharmaceuticals Group Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSichuan
CN

Trademark Events


Event DateEvent Description
Tuesday, November 27, 2018APPLICATION FILING RECEIPT MAILED
Thursday, November 22, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, November 23, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 23, 2018ASSIGNED TO EXAMINER
Thursday, November 29, 2018NON-FINAL ACTION WRITTEN
Friday, November 30, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, December 13, 2018REFUSAL PROCESSED BY MPU
Thursday, December 13, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, December 28, 2018REFUSAL PROCESSED BY IB
Thursday, May 9, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 9, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 10, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 31, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 14, 2019ASSIGNED TO LIE
Wednesday, July 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 23, 2019PUBLISHED FOR OPPOSITION
Tuesday, July 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 8, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, January 8, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, February 3, 2020GENERIC MADRID TRANSACTION CREATED
Thursday, February 10, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 10, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 10, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 10, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, February 10, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, June 9, 2024NEW REPRESENTATIVE AT IB RECEIVED
Monday, February 3, 2020GENERIC MADRID TRANSACTION SENT TO IB
Friday, March 13, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, February 10, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED